Skip to search formSkip to main contentSkip to account menu

cholecystokinin (27-33)

Known as: CCK(27-33), CCK-7, cholecystokinin C-terminal heptapeptide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Peptide FragmentsSincalide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
N α -Carboxyacyl analogues of CCK with a substituted Gly: Interaction with pancreatic and gallbladder CCK receptors
1992
1992
Pharmacological characterization of new cholecystokinin analogues.
1992
1992
The influence of C-terminal cholecystokinin fragments in the circulatory system of rats.
The effects of C-terminal unsulfated cholecystokinin octapeptide (CCK-8US) and its fragments C-terminal heptapeptide (CCK-7), C… 
1991
1991
Synthesis and biological activity of novel, potent and long-acting analogs of AC-CCK-7 with high affinity for peripheral (type A) receptors.
Analogs of cholecystokinin (CCK-7) in which the N-terminal Tyr(SO3H) was acetylated, Asp6 replaced with Thr(SO3H) and Phe7… 
1988
1988
Conformational analysis of possible biologically active (receptor-bound) conformations of peptides derived from cholecystokinin, cerulein and little gastrin and the opiate peptide, Met-enkephalin
1988
1988
A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
1988
1988
Synthesis and analgesic activity of cholecystokinin-heptapeptide analogs with N-terminal substitution.
Analogs of Cholecystokinin-heptapeptide (CCK-7), i.e., two epimers of 3-(-sulfooxyphenyl)-2-methylpropanoyl-Met-Gly-Trp-Met-Asp… 
1987
1987
Suc-Tyr(SE)-Met-Gly-Trp-Met-Asp-beta-phenethylamide(410): a competitive antagonist of cholecystokinin-induced contractions in smooth muscles in vitro.
Suc-Tyr(SE)-Met-Gly-Trp-Met-Asp-beta-phenethylamide(410) has been studied for its ability to antagonize contractile responses of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)